Issue: FDA and Drug Regulation
     
 
En Español

The Power of Independent Thinking

←  ISSUES
Issues
›
Regulation
›
FDA and Drug Regulation
›
Commentary

Showing 161 - 170 of 201 Results.

Hospitals Profit from Drug Discount Program for Poor Americans
John R. Graham | Commentary | Oct. 8, 2014
Save the Children from the FDA
John C. Goodman | Commentary | Oct. 7, 2014
Should You Be Able to Sell Your Kidney?
John C. Goodman | Commentary | Aug. 18, 2014
Can the Exchanges Be Turned into Real Markets?
John C. Goodman | Commentary | July 30, 2014
FDA Meningitis Vaccine Delay Killing Americans
K. Lloyd Billingsley | Commentary | Mar. 12, 2014
Popular Medicare Drug Plans Are Under Assault
John C. Goodman | Commentary | Mar. 10, 2014
Worse Than Death Panels: Cookbook Medicine
John C. Goodman | Commentary | Mar. 10, 2014
Prospects for Repealing PPACA’s Taxes on Medical Devices and Health Insurance
John R. Graham | Commentary | Jan. 16, 2014
How Congress Encourages Shortages of Cancer Drugs
John R. Graham | Commentary | Aug. 31, 2013
User Fees for Medical Devices: Third Time Lucky?
John R. Graham | Commentary | July 12, 2012






  • Catalyst
  • Beyond Homeless
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org
© 2024 INDEPENDENT INSTITUTE, 100 SWAN WAY, OAKLAND CA 94621‑1428 | (510) 632‑1366 | (510) 568‑6040 FAX | SEND EMAIL